Clinical trial NAVIGATE
A Phase 2 Basket Study of the Oral TRK Inhibitor larotrectinib in Subjects with NTRK Fusion-Positive Tumors
| Organ | Multiple |
|---|---|
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | Bayer |
| EudraCT Identifier | 2015-003582-28 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02576431 |
| Inclusion criteria | NTRK |
| Last update |